Literature DB >> 24789463

Investigating retinal toxicity of tempol in a model of isolated and perfused bovine retina.

Kai Januschowski1, Sebastian Mueller, Rebecca Dollinger, Sven Schnichels, Johanna Hofmann, Martin S Spitzer, Karl-Ulrich Bartz-Schmidt, Peter Szurman, Sebastian Thaler.   

Abstract

PURPOSE: Tempol (4-hydroxy-2,2,6,6-tetramethylpiperidinyl-1-oxyl) is a membrane-permeable superoxide dismutase and potentially neuroprotective substance. This study evaluates the retinal tolerance of 0.5 mM, 1 mM, 2 mM, and 5 mM tempol measured by the electroretinogram (ERG) of an isolated and perfused retina whole mount.
METHODS: For functionality testing, bovine retinas were prepared and perfused with an oxygen-saturated standard solution, and the ERG was recorded until stable b-wave amplitudes were reached. Tempol concentrations of 0.5 mM, 1 mM, 2 mM, and 5 mM were tested for 45 minutes. To investigate the effects on photoreceptor function, 1 mM aspartate was added to suppress the b-wave and obtain isolated a-waves. ERG amplitudes were monitored for 100 minutes.
RESULTS: While no toxic effects for concentrations of 0.5 mM and 1 mM tempol could be detected, concentrations of 2 mM tempol and higher caused statistically significant negative effects on the b-wave amplitude (-38 %, p = 0.02 for 2 mM; -54 %, p = 0.02 for 5 mM). The a-wave amplitude remained stable even at higher concentrations.
CONCLUSIONS: Although the photoreceptors seem to have a tolerance to high concentrations of tempol, higher intravitreal concentrations than 1 mM should be considered critical.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24789463     DOI: 10.1007/s00417-014-2632-4

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  25 in total

1.  Endoillumination during vitrectomy and phototoxicity thresholds.

Authors:  P R van den Biesen; T Berenschot; R M Verdaasdonk; H van Weelden; D van Norren
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

2.  Neuroprotective effects of a taurine-containing irrigation solution for vitrectomy.

Authors:  Maximilian Schultheiss; Hannah Ruschenburg; Max Warga; Charlotte Schramm; Kai Januschowski; Sven Schnichels; Tilo Biedermann; Peter Szurman; Martin S Spitzer
Journal:  Retina       Date:  2012-07       Impact factor: 4.256

3.  Testing the biocompatibility of a glutathione-containing intra-ocular irrigation solution by using an isolated perfused bovine retina organ culture model - an alternative to animal testing.

Authors:  Kai Januschowski; Ahmad Zhour; Albert Lee; Ramin Maddani; Sebastien Mueller; Martin S Spitzer; Sven Schnichels; Maximilian Schultheiss; Deshka Doycheva; Karl-Ulrich Bartz-Schmidt; Peter Szurman
Journal:  Altern Lab Anim       Date:  2012-03       Impact factor: 1.303

4.  Neuroprotective effects of the stable nitroxide compound Tempol on 1-methyl-4-phenylpyridinium ion-induced neurotoxicity in the Nerve Growth Factor-differentiated model of pheochromocytoma PC12 cells.

Authors:  Tatiana Lipman; Rinat Tabakman; Philip Lazarovici
Journal:  Eur J Pharmacol       Date:  2006-08-26       Impact factor: 4.432

5.  Evaluating retinal toxicity of a new heavy intraocular dye, using a model of perfused and isolated retinal cultures of bovine and human origin.

Authors:  Kai Januschowski; Sebastian Mueller; Martin S Spitzer; Charlotte Schramm; Deshka Doycheva; Karl-Ulrich Bartz-Schmidt; Peter Szurman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-03-28       Impact factor: 3.117

6.  Tempol protects against intravitreous indocyanine green-induced retinal damage in rats.

Authors:  Sebastian Thaler; Bogomil Voykov; Gabriel Willmann; Michal Fiedorowicz; Robert Rejdak; Florian Gekeler; C Albrecht May; Andreas Schatz; Frank Schuettauf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-03-31       Impact factor: 3.117

7.  Neuroprotection by the stable nitroxide Tempol during reperfusion in a rat model of transient focal ischemia.

Authors:  R Rak; D L Chao; R M Pluta; J B Mitchell; E H Oldfield; J C Watson
Journal:  J Neurosurg       Date:  2000-04       Impact factor: 5.115

Review 8.  Definition of glaucoma: clinical and experimental concepts.

Authors:  Robert J Casson; Glyn Chidlow; John P M Wood; Jonathan G Crowston; Ivan Goldberg
Journal:  Clin Exp Ophthalmol       Date:  2012-04-05       Impact factor: 4.207

9.  The effects of triamcinolone crystals on retinal function in a model of isolated perfused vertebrate retina.

Authors:  Matthias Lüke; Kai Januschowski; Julia Beutel; Max Warga; Salvatore Grisanti; Swaantje Peters; Toni Schneider; Christoph Lüke; Karl Ulrich Bartz-Schmidt; Peter Szurman
Journal:  Exp Eye Res       Date:  2008-04-23       Impact factor: 3.467

10.  Peroxynitrite-mediated oxidative damage to brain mitochondria: Protective effects of peroxynitrite scavengers.

Authors:  Indrapal N Singh; Patrick G Sullivan; Edward D Hall
Journal:  J Neurosci Res       Date:  2007-08-01       Impact factor: 4.164

View more
  3 in total

1.  Protective Effect of Tempol against Cisplatin-Induced Ototoxicity.

Authors:  Cha Kyung Youn; Jun Kim; Eu-Ri Jo; Jeonghyun Oh; Nam Yong Do; Sung Il Cho
Journal:  Int J Mol Sci       Date:  2016-11-18       Impact factor: 5.923

2.  PhTx3-4, a Spider Toxin Calcium Channel Blocker, Reduces NMDA-Induced Injury of the Retina.

Authors:  Nancy Scardua Binda; Charles Porto Petruceli Carayon; Rafael Mourão Agostini; Ana Cristina do Nascimento Pinheiro; Marta Nascimento Cordeiro; Marco Aurélio Romano Silva; Juliana Figueira Silva; Elizete Maria Rita Pereira; Claudio Antonio da Silva Junior; Célio José de Castro Junior; Andre Luiz Sena Guimarães; Marcus Vinicius Gomez
Journal:  Toxins (Basel)       Date:  2016-03-11       Impact factor: 4.546

Review 3.  Organ Cultures for Retinal Diseases.

Authors:  José Hurst; Agnes Fietz; Teresa Tsai; Stephanie C Joachim; Sven Schnichels
Journal:  Front Neurosci       Date:  2020-11-25       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.